Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...
The EU regulator has started its review of a second CAR-T from Gilead Sciences’ Kite Pharma subsidiary, setting up a possible approval before year-end. Like Kite’s already-approved CAR-T ...
A California federal district court denied Gilead Sciences, Inc. and Kite Pharma, Inc.’s motion to dismiss unpaid overtime claims under the Fair Labor Standards Act of two cell therapy specialists ...
Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...
We've been getting creative with the best logo makers for branding your business online. It's difficult to understate the importance of good logo design - it's the quickest way for customers and ...
A new leadership team helmed by Johnson & Johnson alum Paul Stoffels was entrenching Galapagos into cell therapy, but Gilead already had this space covered with Kite Pharma, which it acquired in 2017 ...
Q: Is Kites Flop or Hit? A: The performance of Kites was Flop. Q: What is the overall Box Office Collection of Kites? A: No Data Found.. Q: What is the Day 1 Box Office Collection of Kites?
Gilead Sciences’ Livdelzi (seladelpar) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adults with the rare liver disease primary biliary cholangitis (PBC) ...
Kites of different hues and shapes adorned the sky at Tannirbhavi beach as the two-day ONGC-MRPL Mangaluru International Kite Festival began on Saturday. Organised by Team Mangalore, this is the ...
KITE-363 is under clinical development by Gilead Sciences and currently in Phase II for Burkitt Lymphoma. According to GlobalData, Phase II drugs for Burkitt Lymphoma have a 40% phase transition ...
Gilead is headquartered in Foster City, California, the US. For a complete picture of KITE-363’s drug-specific PTSR and LoA scores, buy the report here. GlobalData, the leading provider of industry ...
Gilead Sciences Inc. and the federal government settled a patent-infringement case in which the US sought $1 billion from the bioscience giant for allegedly using joint research to develop an ...